CNBCLean R·
Biotech stocks are surging. How investors can play the new drug innovation boom
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
Read at CNBC →
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
<iframe src="https://statesidedaily.com/embed/cluster/508d8f544be8bdef2271343a55aebab1ef7c031e" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Biotech stocks are surging. How investors can play the new drug innovation boom"></iframe>